Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. GlaxoSmithKline Pharmaceuticals Limited
  6. News
  7. Summary
    500660   INE159A01016

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

(500660)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021

10/29/2021 | 07:35am EST

GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 10,098.7 million compared to INR 8,793.2 million a year ago. Revenue was INR 10,248.4 million compared to INR 8,883.6 million a year ago. Net income was INR 2,042.4 million compared to INR 764.7 million a year ago. Basic earnings per share from continuing operations was INR 12.06 compared to INR 4.51 a year ago. For the six months, sales was INR 17,998.6 million compared to INR 15,279.1 million a year ago. Revenue was INR 18,465.6 million compared to INR 15,948.7 million a year ago. Net income was INR 3,253.2 million compared to INR 1,873 million a year ago. Basic earnings per share from continuing operations was INR 19.2 compared to INR 11.06 a year ago.


ę S&P Capital IQ 2021
All news about GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
2021GlaxoSmithKline Pharmaceuticals Completes Sale of Karnataka Manufacturing Business in I..
MT
2021Hetero Labs Limited completed the acquisition of Manufacturing Facility at Vemgal from ..
CI
2021GlaxoSmithKline Pharmaceuticals' Consolidated Net Profit Nearly Triples in Fiscal Q2
MT
2021GSK delivers 13% sales growth for the quarter ended September 30, 2021 Innovation and S..
AQ
2021GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter..
CI
2021GLAXOSMITHKLINE PHARMACEUTICALS' : Consolidated Net Profit Climbs in Fiscal Q1
MT
2021Glaxosmithkline Pharmaceuticals Limited Reports Earnings Results for the First Quarter ..
CI
2021GLAXOSMITHKLINE PHARMACEUTICALS LIMI : Ex-dividend day for final dividend
FA
2021Sanofi, GSK get Indian approval for late-stage trial of COVID-19 vaccine
RE
2021GLAXOSMITHKLINE PHARMACEUTICALS : announces results for the quarter and full year ended Ma..
AQ
More news
Financials
Sales 2022 36 362 M 489 M 489 M
Net income 2022 6 366 M 85,6 M 85,6 M
Net cash 2022 12 388 M 167 M 167 M
P/E ratio 2022 44,8x
Yield 2022 2,54%
Capitalization 294 B 3 964 M 3 961 M
EV / Sales 2022 7,76x
EV / Sales 2023 7,26x
Nbr of Employees 4 283
Free-Float 24,5%
Chart GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Duration : Period :
GlaxoSmithKline Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 1 738,15 INR
Average target price 1 649,86 INR
Spread / Average Target -5,08%
EPS Revisions
Managers and Directors
Sridhar Venkatesh Managing Director & Director
Puja Thakur Chief Financial Officer & Executive Director
Renu Sud Karnad Non-Executive Chairman
Priyanka Bhatia Head-Medical Affairs
Ajay A. Nadkarni Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-1.27%3 964
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.72%323 901
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317